Latest news
VERAXA Biotech (VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 18:30:00 GMTMeet the Panelists for the Next-Generation Bioconjugation Panel - chromatographyonline.comchromatographyonline.com · Wed, 05 Aug 2026 15:41:45 GMTTasrif Pharmaceutical granted second US patent for CD155-targeting antibody developed with Abzena's humanisation and immunogenicity platforms - Manufacturing ChemistManufacturing Chemist · Tue, 04 Aug 2026 12:14:55 GMTFujifilm and Taiho Pharmaceutical Enter into Strategic Partnership for Development of Next-Generation Antibody-Drug Conjugate (ADC) Manufacturing Technologies - markets.businessinsider.commarkets.businessinsider.com · Mon, 03 Aug 2026 20:38:41 GMTThe next generation of antibody–drug conjugates - NatureNature · Mon, 03 Aug 2026 09:50:39 GMTKaigene Enters into Exclusive Licensing Agreement with Taisho Pharmaceutical for Next-Generation Autoimmune Asset KG006 in Japan - PR NewswirePR Newswire · Fri, 31 Jul 2026 01:01:00 GMTHow Advanced Manufacturing Strategies Can Support Next-Generation Antibody-Drug Conjugate Innovation - BioPharm InternationalBioPharm International · Thu, 30 Jul 2026 07:00:00 GMTJohnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation - Business WireBusiness Wire · Wed, 29 Jul 2026 21:42:00 GMT